Darnell G, Richardson D R
Department of Medicine, University of Queensland, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
Blood. 1999 Jul 15;94(2):781-92.
We have identified specific iron (Fe) chelators of the pyridoxal isonicotinoyl hydrazone (PIH) class that are far more effective ligands than desferrioxamine (DFO; Richardson et al, Blood 86:4295, 1995; Richardson and Milnes, Blood 89:3025, 1997). In the present study, we have compared the effect of DFO and one of the most active chelators (2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone; 311) on molecular targets involved in proliferation. This was performed to further understand the mechanisms involved in the antitumor activity of Fe chelators. Ligand 311 was far more active than DFO at increasing Fe release from SK-N-MC neuroepithelioma and BE-2 neuroblastoma cells and preventing Fe uptake from transferrin. Like DFO, 311 increased the RNA-binding activity of the iron-regulatory proteins (IRPs). However, despite the far greater Fe chelation efficacy of 311 compared with DFO, a similar increase in IRP-RNA binding activity occurred after 2 to 4 hours of incubation with either chelator, and the binding activity was not inhibited by cycloheximide. These results suggest that, irrespective of the Fe chelation efficacy of a ligand, an increase IRP-RNA binding activity occurred via a time-dependent step that did not require protein synthesis. Further studies examined the effect of 311 and DFO on the expression of p53-transactivated genes that are crucial for cell cycle control and DNA repair, namely WAF1, GADD45, and mdm-2. Incubation of 3 different cell lines with DFO or 311 caused a pronounced concentration- and time-dependent increase in the expression of WAF1 and GADD45 mRNA, but not mdm-2 mRNA. In accordance with the distinct differences in Fe chelation efficacy and antiproliferative activity of DFO and 311, much higher concentrations of DFO (150 micromol/L) than 311 (2.5 to 5 micromol/L) were required to markedly increase GADD45 and WAF1 mRNA levels. The increase in GADD45 and WAF1 mRNA expression was seen only after 20 hours of incubation with the chelators and was reversible after removal of the ligands. In contrast to the chelators, the Fe(III) complexes of DFO and 311 had no effect on increasing GADD45 and WAF1 mRNA levels, suggesting that Fe chelation was required. Finally, the increase in GADD45 and WAF1 mRNAs appeared to occur by a p53-independent pathway in SK-N-MC and K562 cells, because these cell lines lack functional p53. Our results suggest that GADD45 and WAF1 may play important roles in the cell cycle arrest observed after exposure to these chelators.
我们已经鉴定出了吡啶醛异烟酰腙(PIH)类的特定铁(Fe)螯合剂,它们作为配体比去铁胺(DFO;Richardson等人,《血液》86:4295,1995;Richardson和Milnes,《血液》89:3025,1997)更有效。在本研究中,我们比较了DFO和活性最高的螯合剂之一(2-羟基-1-萘甲醛异烟酰腙;311)对参与增殖的分子靶点的影响。这样做是为了进一步了解铁螯合剂抗肿瘤活性所涉及的机制。配体311在增加SK-N-MC神经上皮瘤细胞和BE-2神经母细胞瘤细胞的铁释放以及阻止从转铁蛋白摄取铁方面比DFO活性高得多。与DFO一样,311增加了铁调节蛋白(IRP)的RNA结合活性。然而,尽管311与DFO相比铁螯合功效要高得多,但用任何一种螯合剂孵育2至4小时后,IRP-RNA结合活性都有类似的增加,并且这种结合活性不受环己酰亚胺的抑制。这些结果表明,无论配体的铁螯合功效如何,IRP-RNA结合活性的增加是通过一个不依赖蛋白质合成的时间依赖性步骤发生的。进一步的研究考察了311和DFO对p53反式激活基因表达的影响,这些基因对细胞周期控制和DNA修复至关重要,即WAF1、GADD45和mdm-2。用DFO或311孵育3种不同的细胞系导致WAF1和GADD45 mRNA的表达出现明显的浓度和时间依赖性增加,但mdm-2 mRNA没有增加。与DFO和311在铁螯合功效和抗增殖活性方面的明显差异一致,需要比311(2.5至5微摩尔/升)高得多的DFO浓度(150微摩尔/升)才能显著增加GADD45和WAF1 mRNA水平。只有在用螯合剂孵育20小时后才观察到GADD45和WAF1 mRNA表达的增加,并且在去除配体后是可逆的。与螯合剂相反,DFO和311的Fe(III)络合物对增加GADD45和WAF1 mRNA水平没有影响,这表明需要铁螯合。最后,在SK-N-MC和K562细胞中,GADD45和WAF1 mRNA的增加似乎是通过一条不依赖p53的途径发生的,因为这些细胞系缺乏功能性p53。我们的结果表明,GADD45和WAF1可能在暴露于这些螯合剂后观察到的细胞周期停滞中起重要作用。